The Stock Playbook : ETF's

Issue: 4/23/2008

Dave Dispennette — Wed, 23 Apr 2008 22:00:00 GMT

Foreign Stocks

SDA @ $21.56 (Sadia) is a Brazilian processor of frozen and refrigerated food products and poultry and pork products sold worldwide. Revenues have increased between 32% and 51% during the last four quarters. Earnings have increased 50%, 525%, 229% and 61% during the same time frame. We are adding SDA to OME and CQB in this group as it breaks out of a base. We are establishing a position here and will add to position on pull back to $18. Our stop loss will be set at $17.20.

JST @ $35.73 (Jinpan International) is a Chinese manufacturer of cast resin transformers used to convert high voltage electric transmissions to lower voltages. We originally bought this stock at $9.35 on 1/31/06 and are ready to revisit here at these levels. We will establish half a position here and will add the second half on a pull back to $30. Our stop loss will be set at $28.

ETF's

FXI @ $160.05 (Ishares Ftse/Xinhua China) is the ETF we play when we want some exposure to China. After being beaten down from $220 in October to a low of $120 in March, the FXI has reclaimed its 200 day moving average today with a better than 7% gain today. We are establishing half a position here and will add on a pull back to $150. Our stop loss will be set at $140 as we head into the summer Olympics. For the options players among us, we like the November $80 Calls (IKI KW) at $80.60 much better than the ETF.

This newsletter has been sent to you for informative purposes only and in no event should be construed as a representation by The Stock Playbook or its employees as an offer to sell or solicitation of an offer to buy any securities. The factual information given is taken from sources we believe to be reliable, but is not guaranteed as to its accuracy or completeness. The opinions expressed should be given only such weight as opinions warrant. employees and/or family members may have a position in the securities mentioned and may make purchase and/or sales of such securities from time to time in the open market or otherwise Recipients of The Stock Playbook prohibited from, directly or indirectly, distributing, forwarding , plagiarizing or copying any part of this message without expressed written consent from The Stock Playbook. Some content may have been based, at least in part, on material gathered from Investor's Business Daily ® and/or YAHOO!®

Issue: 4/1/2008

Dave Dispennette — Tue, 01 Apr 2008 19:47:00 GMT

IPO's and New Issues

DMAN @ $10.53 (Demandtec) provides consumer demand management software for retailers and consumer product companies. Revenues have accelerated 25%, 32%, 40% and 49% during the last four quarters. They are expected to announce their first profit this year and then grow earnings 238% next year. We've made money on this stock in the past and are re-establishing a position by buying half here and we will add the remaining half on a pull back to $9. Our stop loss will be set at $8.50.

ETF's

PBW @ $20.15 (Powershares Clean Energy) is an ETF seeking performance corresponding to the Wilderhill Clean Energy index. We've made money in this ETF before and are re-visiting it here. We will establish half a position here and enter the remaining half on a pull back to $18.50. Our stop loss will be set at $18.

Issue: 3/19/2008

Dave Dispennette — Wed, 19 Mar 2008 20:01:00 GMT

The Playbook 100

CELG @ $57.68 (Celgene) develops therapies to treat cancer and immune-inflammatory related diseases. Revenues have increased between 43% and 76% during each of the last four quarters. Earnings have increased between 72% and 136% during the same time frame and are expected to grow 43% this year and another 50% in 2009 to $2.28 a share. We've made money a few times in this company over the last few years and feel a good risk to reward is being offered by establishing a position here with a tight stop at $53. Our option players have a nice option listed below.

IPO's and New Issues

V @ $56.50 (Visa) gapped higher, so we didn't chase it. We will wait for a pull back toward the $45 level for now and until then, feel Mastercard (MA) offers us a better value.

ETF's

FXI @ $123.69 (Ishares Xinhua China) is an exchange traded fund seeking performance corresponding to the FTSE/Xinhua China 25 Index. We will establish a position on continued weakness that allows us an entry at $115 and will place a tight stop at $110.

Options

VCS AF @ $29.90 (Celgene January 2009 $30 Calls) are only costing us $2.22 in time value and could be a huge winner on a Celgene breakout above $60. Otherwise, we risk $4 to the downside for potentially $20 plus to the upside.